EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $5.33M in the quarter ending June 30, 2025, a decrease of -43.73%. This brings the company's revenue in the last twelve months to $51.90M, up 2.99% year-over-year. In the year 2024, EyePoint Pharmaceuticals had annual revenue of $43.27M, down -5.97%.

• Revenue (ttm): $51.90M
• Revenue Growth: +2.99%
• P/S Ratio: 16.64
• Revenue / Employee: $314,533
• Employees: 165
• Market Cap: 920.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.27M	-2.75M	-5.97%
Dec 31, 2023	46.02M	4.61M	11.14%
Dec 31, 2022	41.40M	4.47M	12.09%
Dec 31, 2021	36.94M	2.50M	7.27%
Dec 31, 2020	34.44M	14.07M	69.10%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.